How will GINA influence participation in pharmacogenomics research and clinical testing?

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 5, 2009, Pages 472-475

  Dressler, L G ^a   Terry, S F ^b  

^a University of North Carolina   (United States)

^b GENETIC ALLIANCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFUSION; EUROPE; GENETIC ORGANIZATION; GENETICS; GENOME; HEALTH INSURANCE; HUMAN; LAW; MEDICINE; PHARMACOGENETICS; PRIORITY JOURNAL; SHORT SURVEY;

EMPLOYMENT; GENETIC PRIVACY; GENETIC TESTING; GOVERNMENT REGULATION; HUMANS; INSURANCE COVERAGE; INSURANCE SELECTION BIAS; INSURANCE, HEALTH; PHARMACOGENETICS; PREJUDICE; RESEARCH DESIGN; UNITED STATES;

EID: 70350241800     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.146     Document Type: Short Survey

References (12)

1. Genetic Information Nondiscrimination Act of 2008, Public Law 110-233, Stat. 122 (21 May 2008) (2008).
2. Hudson, K.L., Holohan, M.K. & Collins, F.S. Keeping pace with the times-the Genetic Information Nondiscrimination Act of 2008. N. Engl. J. Med. 358, 2661-2663 (2008).
3. Coalition for Genetic Fairness. What Does GINA Mean? A Guide to the Genetic Information Nondiscrimination Act (2008). Accessed 23 February 2009.
4. Genetic and Public Policy Center, Genetics and Public Policy Center at Johns Hopkins University. GINA Project 2008 (2008). Accessed 23 February 2009.
5. Office for Human Research Protections, US Department of Health and Human Services. Guidance on the Genetic Information Nondiscrimination Act: Implications for Investigators and Institutional Review Boards http://www.hhs.gov/ohrp/humansubjects/ guidance/gina.html (4 March, 2009). Accessed 1 April 2009.
6. Van Hoyweghen, I. & Horstman, K. European practices of genetic information and insurance: lessons for the Genetic Information Nondiscrimination Act. JAMA 300, 326-327 (2008).
7. Hudson, K.L. Prohibiting genetic discrimination. N. Engl. J. Med. 356, 2021-2023 (2007).
8. Billings, P.R. Genetic nondiscrimination. Nat. Genet. 37, 559-560 (2005).
9. Geller, L.N., Alper, J.S., Billings, P.R., Barash, C.I., Beckwith, J. & Natowicz, M.R. Individual, family, and societal dimensions of genetic discrimination: a case study analysis. Sci. Eng. Ethics 2, 71-88 (1996).
10. Altman, R.B., Benowitz, N., Gurwitz, D., Lunshof, J., Relling, M., Lamba, J. et al. Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing. Pharmacogenomics 8, 519 (2007).
11. Dressler, L. Human Specimens, Cancer Research and Drug Development: How Science Policy Can Promote Progress and Protect Research Participants. Institute of Medicine National Cancer Advisory Board. Invited background paper http://www.iom. edu/CMS/3798/12774/26207.aspx 2005). Accessed 23 February 2009.
12. Genomics and Personalized Medicine Act of 2008. 110th Congress 2nd edn. http://olpa.od.nih.gov/tracking/110/senate-bills/session1/s-976.asp (2008).